ARQT logo

Arcutis Biotherapeutics (ARQT) Cash From Operations

Annual CFO

-$112.16 M
+$134.90 M+54.60%

December 31, 2024


Summary


Performance

ARQT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARQTcash flowmetrics:

Quarterly CFO

-$748.00 K
+$33.94 M+97.84%

December 31, 2024


Summary


Performance

ARQT Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARQTcash flowmetrics:

TTM CFO

-$112.16 M
+$55.50 M+33.10%

December 31, 2024


Summary


Performance

ARQT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARQTcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ARQT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+54.6%+98.7%+54.6%
3 y3 years+35.8%+98.3%+57.2%
5 y5 years-161.8%+98.3%+57.2%

ARQT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+56.5%at high+99.1%at high+60.7%
5 y5-year-161.8%+56.5%at high+99.1%-161.8%+60.7%
alltimeall time-2871.1%+56.5%at high+99.1%-1485.5%+60.7%

Arcutis Biotherapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$112.16 M(-54.6%)
-$748.00 K(-97.8%)
-$112.16 M(-33.1%)
Sep 2024
-
-$34.69 M(-23.1%)
-$167.65 M(-5.3%)
Jun 2024
-
-$45.12 M(+42.8%)
-$176.95 M(-10.8%)
Mar 2024
-
-$31.60 M(-43.8%)
-$198.32 M(-19.7%)
Dec 2023
-$247.06 M(-4.1%)
-$56.24 M(+27.9%)
-$247.06 M(-5.7%)
Sep 2023
-
-$43.98 M(-33.8%)
-$261.88 M(-8.3%)
Jun 2023
-
-$66.48 M(-17.2%)
-$285.59 M(+1.6%)
Mar 2023
-
-$80.34 M(+13.1%)
-$281.08 M(+9.1%)
Dec 2022
-$257.71 M(+47.6%)
-$71.06 M(+5.0%)
-$257.71 M(+8.1%)
Sep 2022
-
-$67.69 M(+9.2%)
-$238.36 M(+12.7%)
Jun 2022
-
-$61.98 M(+8.8%)
-$211.55 M(+14.1%)
Mar 2022
-
-$56.98 M(+10.2%)
-$185.40 M(+6.2%)
Dec 2021
-$174.63 M
-$51.71 M(+26.5%)
-$174.63 M(+12.3%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$40.88 M(+14.1%)
-$155.49 M(+4.9%)
Jun 2021
-
-$35.83 M(-22.4%)
-$148.30 M(+7.3%)
Mar 2021
-
-$46.20 M(+41.9%)
-$138.23 M(+22.3%)
Dec 2020
-$113.03 M(+163.9%)
-$32.57 M(-3.3%)
-$113.03 M(+16.2%)
Sep 2020
-
-$33.69 M(+30.8%)
-$97.26 M(+30.9%)
Jun 2020
-
-$25.76 M(+22.6%)
-$74.29 M(+30.9%)
Mar 2020
-
-$21.01 M(+25.1%)
-$56.77 M(+32.5%)
Dec 2019
-$42.84 M(+204.1%)
-$16.80 M(+56.7%)
-$42.84 M(+64.5%)
Sep 2019
-
-$10.72 M(+30.1%)
-$26.04 M(+70.0%)
Jun 2019
-
-$8.24 M(+16.5%)
-$15.32 M(+116.5%)
Mar 2019
-
-$7.07 M
-$7.07 M
Dec 2018
-$14.09 M(+273.1%)
-
-
Dec 2017
-$3.77 M
-
-

FAQ

  • What is Arcutis Biotherapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics annual CFO year-on-year change?
  • What is Arcutis Biotherapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics quarterly CFO year-on-year change?
  • What is Arcutis Biotherapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics TTM CFO year-on-year change?

What is Arcutis Biotherapeutics annual cash flow from operations?

The current annual CFO of ARQT is -$112.16 M

What is the all time high annual CFO for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high annual cash flow from operations is -$3.77 M

What is Arcutis Biotherapeutics annual CFO year-on-year change?

Over the past year, ARQT annual cash flow from operations has changed by +$134.90 M (+54.60%)

What is Arcutis Biotherapeutics quarterly cash flow from operations?

The current quarterly CFO of ARQT is -$748.00 K

What is the all time high quarterly CFO for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high quarterly cash flow from operations is -$748.00 K

What is Arcutis Biotherapeutics quarterly CFO year-on-year change?

Over the past year, ARQT quarterly cash flow from operations has changed by +$55.50 M (+98.67%)

What is Arcutis Biotherapeutics TTM cash flow from operations?

The current TTM CFO of ARQT is -$112.16 M

What is the all time high TTM CFO for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high TTM cash flow from operations is -$7.07 M

What is Arcutis Biotherapeutics TTM CFO year-on-year change?

Over the past year, ARQT TTM cash flow from operations has changed by +$134.90 M (+54.60%)